Please be aware that this website relies on the use of cookies to function correctly and involves some cookies being downloaded onto your device. By continuing to use this website, you agree to our use of these cookies. This helps us to improve the content of the website so that it is more useful and relevant to you. For more information please see our Privacy Policy.

PACE

Patient Access to Cancer care Excellence


A Global Vision

Faster steps forward: towards cures for cancer and access to best treatment and care for individual patients.

Learn more about PACE

Kenneth R. Paterson, M.D.

Educated and trained in Glasgow, Dr. Paterson was appointed consultant physician with interest in diabetes mellitus at Glasgow Royal Infirmary in 1986. In addition to his clinical work in a busy city-centre diabetes service, he was actively involved in the wider world of diabetes, forming the Glasgow Local Diabetes Services Advisory Group and chairing a SIGN guideline development group looking at diabetic renal disease.

He has also worked for the British Diabetic Association (now Diabetes UK), chairing both its Professional Advisory Committee and Project Grant Committee, and served on the Council of the European Association for the Study of Diabetes (EASD). He was Honorary Secretary of the Royal College of Physicians & Surgeons of Glasgow from 2001 to 2004 and is currently a Member of the Board of the Faculty of Pharmaceutical Medicine. He was also Clinical Director of Medicine for North-East Glasgow (Glasgow Royal Infirmary and Stobhill Hospital) from 2006 to 2008.

His other interests include clinical pharmacology and therapeutics and, after many years as Vice-Chair of his local Area Drug and Therapeutics Committee, became Chair of the New Drugs Committee of the Scottish Medicines Consortium (SMC) in 2004 and held the Chair of SMC from 2008 to 2011.

Ken recently stepped down from his full-time clinical post but is continuing his interests in health technology assessment of medicines and medicines management as well as clinical diabetes.